Determining the safety and feasibility of unilateral cell therapy delivery to the substantia nigra for the goal of disease modification

Autor:	Greg A. Gerhardt, John T. Slevin, N. El Seblani, Tripp Hines, Tritia R. Yamasaki, Jorge E. Quintero, Zain Guduru, Lisa M. Koehl, C. van Horne, Julie A. Gurwell
Rok vydání:	2020
Předmět:	Cell therapy Pathology medicine.medical_specialty Neurology Disease modification business.industry Medicine Substantia nigra Neurology (clinical) Geriatrics and Gerontology business
Zdroj:	Parkinsonism & Related Disorders. 79:e14
ISSN:	1353-8020
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fe2410d18b4f0d09e750a6211bde3729 https://doi.org/10.1016/j.parkreldis.2020.06.077 Zobrazit plný text záznamu Full Text from ScienceDirect